National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
   
 
Results: 1 -7 of 7         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


20 and over


Other


ENCITJ-GC01
NCT00503321


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


20 to 80


Other


HGCSG-CAD
NCT00209742


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


20 to 80


Other


HKIT-GC
NCT00216034


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


20 to 80


Other


MCSGO-CCTG-0501
NCT00385970


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


20 to 79


Other


ICOG-CC01
NCT00497107


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


20 to 80


Other


TMOG-GC01
NCT00687843


7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


20 to 69


Other


RNCLC-01
NCT00546130

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov